GREEN THUMB INDS (R9U2.F) Financials

R9U2.F Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 2.5 billion 786.8 million
2023-09-30 2.5 billion 792.3 million
2023-06-30 2.5 billion 807.0 million
2023-03-31 2.5 billion 812.0 million

R9U2.F Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 34.7 million 7.4 million
2023-09-30 6.6 million 7.2 million
2023-06-30 -46.1 million 7.4 million
2023-03-31 9.7 million 6.2 million

R9U2.F Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 3.2 million
2023-09-30 10.5 million
2023-06-30 13.4 million
2023-03-31 9.1 million

R9U2.F Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 - - 261.8 million
2023-09-30 - - 261.8 million
2023-06-30 - - 248.3 million
2023-03-31 - - 263.4 million

R9U2.F Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 235.4 million
2023-09-30 239.1 million
2023-06-30 238.0 million
2023-03-31 236.8 million

R9U2.F Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 36.4 million - 92.3 million -
2023-09-30 54.2 million - 84.8 million -
2023-06-30 64.4 million - 84.2 million -
2023-03-31 64.4 million - 80.5 million -

R9U2.F Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 278.2 million 135.5 million
2023-09-30 275.4 million 141.6 million
2023-06-30 252.4 million 127.1 million
2023-03-31 248.5 million 123.8 million

R9U2.F

Price: €11.24

52 week price:
5.85
14.40

Earnings Per Share: 0.14 EUR

P/E Ratio: 126.70

Exchange: FRA

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 1261

Market Capitalization: 3.2 billion

Links: